On Nov 05, major Wall Street analysts update their ratings for $Choice Hotels International (CHH.US)$, with price targets ranging from $122 to $123.
Goldman Sachs analyst Lizzie Dove maintains with a sell rating.
J.P. Morgan analyst Joseph Greff maintains with a sell rating, and adjusts the target price from $117 to $122.
Barclays analyst Brandt Montour maintains with a sell rating, and adjusts the target price from $112 to $123.
Truist Financial analyst Patrick Scholes maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Choice Hotels International (CHH.US)$'s main analysts recently are as follows:
Following the Q3 report, it was noted that Choice Hotels experienced a RevPAR shortfall but an increase in EBITDA guidance. The report suggests that the quarter contained elements that catered to a diverse set of interests.
Here are the latest investment ratings and price targets for $Choice Hotels International (CHH.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
